226 related articles for article (PubMed ID: 20377392)
1. Combined analysis of the glia secretome and the CSF proteome: neuroinflammation and novel biomarkers.
Suk K
Expert Rev Proteomics; 2010 Apr; 7(2):263-74. PubMed ID: 20377392
[TBL] [Abstract][Full Text] [Related]
2. Enhanced detection of CNS cell secretome in plasma protein-depleted cerebrospinal fluid.
Thouvenot E; Urbach S; Dantec C; Poncet J; Séveno M; Demettre E; Jouin P; Touchon J; Bockaert J; Marin P
J Proteome Res; 2008 Oct; 7(10):4409-21. PubMed ID: 18774838
[TBL] [Abstract][Full Text] [Related]
3. Proteomics analysis of prefractionated human lumbar cerebrospinal fluid.
Yuan X; Desiderio DM
Proteomics; 2005 Feb; 5(2):541-50. PubMed ID: 15627968
[TBL] [Abstract][Full Text] [Related]
4. The secretome signature of reactive glial cells and its pathological implications.
Jha MK; Seo M; Kim JH; Kim BG; Cho JY; Suk K
Biochim Biophys Acta; 2013 Nov; 1834(11):2418-28. PubMed ID: 23269363
[TBL] [Abstract][Full Text] [Related]
5. Proteomics in molecular medicine: applications in central nervous systems disorders.
Rohlff C
Electrophoresis; 2000 Apr; 21(6):1227-34. PubMed ID: 10786895
[TBL] [Abstract][Full Text] [Related]
6. Proteome studies of CSF in AD patients.
Davidsson P; Sjögren M
Mech Ageing Dev; 2006 Feb; 127(2):133-7. PubMed ID: 16293296
[TBL] [Abstract][Full Text] [Related]
7. 2D DIGE of the cerebrospinal fluid proteome in neurological diseases.
Tumani H; Lehmensiek V; Lehnert S; Otto M; Brettschneider J
Expert Rev Proteomics; 2010 Feb; 7(1):29-38. PubMed ID: 20121474
[TBL] [Abstract][Full Text] [Related]
8. Glia-based biomarkers and their functional role in the CNS.
Jha MK; Suk K
Expert Rev Proteomics; 2013 Feb; 10(1):43-63. PubMed ID: 23414359
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the human cerebrospinal fluid phosphoproteome by titanium dioxide affinity chromatography and mass spectrometry.
Bahl JM; Jensen SS; Larsen MR; Heegaard NH
Anal Chem; 2008 Aug; 80(16):6308-16. PubMed ID: 18702456
[TBL] [Abstract][Full Text] [Related]
10. Integrated analysis of the cerebrospinal fluid peptidome and proteome.
Zougman A; Pilch B; Podtelejnikov A; Kiehntopf M; Schnabel C; Kumar C; Mann M
J Proteome Res; 2008 Jan; 7(1):386-99. PubMed ID: 18052119
[TBL] [Abstract][Full Text] [Related]
11. Proteome of brain glia: the molecular basis of diverse glial phenotypes.
Jha MK; Kim JH; Suk K
Proteomics; 2014 Mar; 14(4-5):378-98. PubMed ID: 24124134
[TBL] [Abstract][Full Text] [Related]
12. Brain iron homeostasis.
Moos T
Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
[TBL] [Abstract][Full Text] [Related]
13. Differential protein expression in male and female human lumbar cerebrospinal fluid using iTRAQ reagents after abundant protein depletion.
Ogata Y; Charlesworth MC; Higgins L; Keegan BM; Vernino S; Muddiman DC
Proteomics; 2007 Oct; 7(20):3726-34. PubMed ID: 17853512
[TBL] [Abstract][Full Text] [Related]
14. [CSF biomarkers: proteomics investigations and clinical applications in neurodegenerative disorders].
Gabelle A; Roche S; Lehmann S
Rev Neurol (Paris); 2009 Mar; 165(3):213-22. PubMed ID: 18808768
[TBL] [Abstract][Full Text] [Related]
15. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
Ekegren T; Hanrieder J; Bergquist J
J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
[TBL] [Abstract][Full Text] [Related]
16. A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry.
Pan S; Zhu D; Quinn JF; Peskind ER; Montine TJ; Lin B; Goodlett DR; Taylor G; Eng J; Zhang J
Proteomics; 2007 Feb; 7(3):469-73. PubMed ID: 17211832
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
Chiasserini D; van Weering JR; Piersma SR; Pham TV; Malekzadeh A; Teunissen CE; de Wit H; Jiménez CR
J Proteomics; 2014 Jun; 106():191-204. PubMed ID: 24769233
[TBL] [Abstract][Full Text] [Related]
18. Identification of brain cell death associated proteins in human post-mortem cerebrospinal fluid.
Burgess JA; Lescuyer P; Hainard A; Burkhard PR; Turck N; Michel P; Rossier JS; Reymond F; Hochstrasser DF; Sanchez JC
J Proteome Res; 2006 Jul; 5(7):1674-81. PubMed ID: 16823975
[TBL] [Abstract][Full Text] [Related]
19. Conditioned media from cell lines: a complementary model to clinical specimens for the discovery of disease-specific biomarkers.
Dowling P; Clynes M
Proteomics; 2011 Feb; 11(4):794-804. PubMed ID: 21229588
[TBL] [Abstract][Full Text] [Related]
20. Entering a new era of rational biomarker discovery for early detection of melanoma metastases: secretome analysis of associated stroma cells.
Paulitschke V; Kunstfeld R; Mohr T; Slany A; Micksche M; Drach J; Zielinski C; Pehamberger H; Gerner C
J Proteome Res; 2009 May; 8(5):2501-10. PubMed ID: 19222175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
